LabCorp Expands HCV PGx Testing With New GenoSure NS3/4A Rx-Resistance Dx

LabCorp said the nucleic acid-sequencing assay is "the first in a series" of HCV drug-resistance tests developed by Monogram Biosciences to help physicians clinically evaluate HCV direct-acting antivirals.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.